HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced somatostatin-like immunoreactivity in cerebral cortex in nonfamilial dysphasic dementia.

Abstract
A nonfamilial syndrome is described in two middle-aged men who presented with progressive aphasia without incipient signs of cognitive impairment. In each case, 2 years elapsed before progressive functional decline or behavioral disabilities supervened. Radiologic studies documented asymmetric left cerebral atrophy that was progressive. The structure of the language disintegration was distinctive and not like that in Alzheimer's disease. Pathologic studies performed at postmortem examination of one patient documented asymmetric cerebral atrophy with nonspecific histopathologic changes. Biochemical studies revealed normal tissue levels of choline acetyltransferase activity, but reduced somatostatin-like immunoreactivity. Since cerebral somatostatin is largely present in intrinsic cortical neurons, while cholinergic innervation is largely derived from the basal forebrain, these findings suggest that nonfamilial dysphasic dementia may be an example of a distinct class of dementia due to intrinsic cortical degeneration, with sparing of the basal forebrain.
AuthorsM F Mehler, D S Horoupian, P Davies, D W Dickson
JournalNeurology (Neurology) Vol. 37 Issue 9 Pg. 1448-53 (Sep 1987) ISSN: 0028-3878 [Print] United States
PMID2888051 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Somatostatin
  • Choline O-Acetyltransferase
Topics
  • Aphasia (diagnostic imaging, metabolism, pathology)
  • Atrophy (pathology)
  • Brain (diagnostic imaging, metabolism, pathology)
  • Choline O-Acetyltransferase (metabolism)
  • Dementia (metabolism, pathology)
  • Histocytochemistry
  • Humans
  • Male
  • Middle Aged
  • Somatostatin (metabolism)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: